Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Before use, it needs to be dissolved with liquid to become an injectable liquid form
Separate-vial planning can still use 10 mg of each compound, but those vials must be tracked independently
While all three forms injectable, oral, and capsule offer unique advantages, they differ dramatically in bioavailability, scientific backing, and real-world outcomes
The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
Safety & Candidacy BPC/TB-15 high-dose therapy requires careful medical evaluation to ensure appropriate candidacy
US$ 20.62
US$ 26.25
US$ 28.70
